Psychosocial interventions for smoking cessation in patients with coronary heart disease

Barth, Jürgen; Critchley, Julia; Bengel, Jürgen

doi:10.1002/14651858.cd006886.pub2

Cited by 74 publications

(48 citation statements)

References 204 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The trials did seem to be effective in reducing the risk of smoking, albeit only a small decrease in risk, even though all but one were not designed specifically as smoking cessation programmes. This is in agreement with existing findings that smoking cessation programmes are effective in CHD patients [40]. Although secondary prevention guidelines for CHD tend to focus on pharmacological management of risk factors (e.g.…”

Section: Discussionsupporting

confidence: 92%

Can We Identify the Active Ingredients of Behaviour Change Interventions for Coronary Heart Disease Patients? A Systematic Review and Meta-Analysis

et al. 2016

View full text Add to dashboard Cite

BackgroundThe main behaviour change intervention available for coronary heart disease (CHD) patients is cardiac rehabilitation. There is little recognition of what the active ingredients of behavioural interventions for CHD might be. Using a behaviour change technique (BCT) framework to code existing interventions may help to identify this. The objectives of this systematic review are to determine the effectiveness of CHD behaviour change interventions and how this may be explained by BCT content and structure.Methods and FindingsA systematic search of Medline, EMBASE and PsycInfo electronic databases was conducted over a twelve year period (2003–2015) to identify studies which reported on behaviour change interventions for CHD patients. The content of the behaviour change interventions was coded using the Coventry Aberdeen and London—Refined (CALO-RE) taxonomy. Meta-regression analyses examined the BCT content as a predictor of mortality. Twenty two papers met the criteria for this review, reporting data on 16,766 participants. The most commonly included BCTs were providing information, and goal setting. There was a small but significant effect of the interventions on smoking (risk ratio (RR) = 0.89, 95% CI 0.81–0.97). The interventions did not reduce the risk of CHD events (RR = 0.86, 95% CI 0.68, 1.09), but significantly reduced the risk of mortality (RR = 0.82, 95% CI 0.69, 0.97). Sensitivity analyses did not find that any of the BCT variables predicted mortality and the number of BCTs included in an intervention was not associated with mortality (β = -0.02, 95% CI -0.06–0.03).ConclusionsBehaviour change interventions for CHD patients appear to have a positive impact on a number of outcomes. Using an existing BCT taxonomy to code the interventions helped us to understand which were the most commonly used techniques, providing information and goal setting, but not the active components of these complex interventions.

show abstract

Section: Discussionsupporting

confidence: 92%

Can We Identify the Active Ingredients of Behaviour Change Interventions for Coronary Heart Disease Patients? A Systematic Review and Meta-Analysis

et al. 2016

View full text Add to dashboard Cite

show abstract

“…For a specific example, tobacco use is a known major contributor to cardiovascular disease. While cardiac patients who use tobacco would benefit from quitting smoking, most cardiac patients who smoke resume smoking within 6 months of diagnosis (Barth et al, 2015). Additionally, smoking cessation rates following a cardiac event have not increased over time as they have in the general population (Sochor et al, 2015).…”

Section: Introductionmentioning

confidence: 99%

Trends in tobacco use among US adults with chronic health conditions: National Survey on Drug Use and Health 2005–2013

Stanton

Keith

Gaalema

et al. 2016

Preventive Medicine

View full text Add to dashboard Cite

Introduction Chronic conditions are among the most common and costly of all health problems. Addressing tobacco use among adults with chronic conditions is a public health priority due to high prevalence as well as greater potential harm from continued use. Methods Data were drawn from 9 years (2005–2013) of the U.S. National Survey on Drug Use and Health. Adult (≥18 years) tobacco use included any past 30-day use of cigarettes, cigars, pipes, or smokeless tobacco. Chronic conditions examined included anxiety, asthma, coronary heart disease, depression, diabetes, hepatitis, HIV, hypertension, lung cancer, stroke, and substance abuse. Controlling for sociodemographics, trends in product use for most conditions and a composite of any condition among those with chronic conditions were compared to respondents with no condition in weighted logistic regression analyses. Results Cigarette smoking declined significantly over time among adults with no chronic condition. Adults with one or more chronic condition showed no comparable decrease, with cigarette smoking remaining especially high among those reporting anxiety, depression, and substance abuse. Cigar and pipe use remained stable and more prevalent among those with any chronic condition, with the exception of pipe use declining among those with heart disease. Smokeless tobacco use increased over time, with higher prevalence among those with asthma, mental health, and substance abuse conditions. Conclusions These findings have tobacco control and regulatory implications for addressing higher tobacco use among adults with chronic conditions. Provider advice and cessation resources targeting tobacco use among those with chronic conditions are recommended.

show abstract

“…Smoking cessation interventions with a follow-up period of more than 1 month delivered outside the hospital unit achieve enhanced cessation rates in cardiac patients compared to usual care, and the effect increases with the frequency of patient contact (Barth et al, 2015;Rigotti et al, 2012;Smith & Burgess, 2009;Stead, Hartmann-Boyce, Perera, & Lancaster, 2013). Interventions combining highfrequency behavioral counseling with nicotine replacement therapy (NRT) appear to be most promising for increasing cessation rates (Rigotti et al, 2012;Stead, Koilpillai, Fanshawe, & Lancaster, 2016;Stead, Koilpillai, & Lancaster, 2015).…”

Section: Introductionmentioning

confidence: 99%

“…Although this intervention had a modest effect on smoking behavior in the short term, its impact was hindered due to implementation difficulties in practice (Bolman, de Vries, & Mesters, 2002;Segaar et al, 2007), and it was not intensive enough to achieve long-term effects (Bolman, de Vries, & van Breukelen, 2002). Low-intensity interventions consisting of brief advice on quitting or counseling during patients' admission with limited follow-up have not been effective in terms of achieving long-term benefits by helping cardiac patients to quit smoking (Barth, Jacob, Daha, & Critchley, 2015;Rigotti, Clair, Munafo, & Stead, 2012). In this study, two forms of a 3-month intervention continuing after hospital discharge were evaluated in a randomized trial.…”

mentioning

confidence: 99%

Feasibility and acceptability of a telephone‐ and face‐to‐face‐delivered counseling intervention for smoking cessation in Dutch patients with coronary heart disease

Lechner

Mudde

Vries

et al. 2017

Research in Nursing & Health

View full text Add to dashboard Cite

Intensive behavioral counseling interventions combined with nicotine replacement therapy have increased smoking abstinence rates in cardiac patients, but little is known about their feasibility when initiated upon hospital admission and continued post-discharge. The current study was an evaluation of the use, appreciation, and fidelity of two post-discharge counseling interventions designed for cardiac patients to quit smoking that differed in their delivery mode. In a controlled trial with cross-over randomization at the cardiac unit level, hospitalized smokers in eight cardiac units of eight Dutch hospitals were assigned either telephone counseling (n = 223) or nurse-administered face-to-face counseling (n = 157) using the Ask-Advise-Refer strategy. Eligible patients also received nicotine replacement therapy. Data based on counselors' registration forms and patients' telephone surveys at 6-month follow-up were analyzed. Most patients (>90%) participated in at least one counseling session, and the majority participated in at least five out of a maximum of seven sessions. Higher levels of adherence to either the telephone or face-to-face counseling sessions were associated with higher smoking abstinence rates at the 6-month follow-up, whereas higher nicotine patch use was not associated with abstinence. Patients positively evaluated the content, duration, and number of sessions, and rated the face-to-face counseling significantly better than the telephone counseling for quitting smoking. The counselors largely complied with the intervention protocols. The current intervention offers evidence of feasibility and may improve outpatient continuity of smoking care. Monitoring the use and delivery of such complex interventions is recommended to promote effective dissemination in cardiac practice.

show abstract

Psychosocial interventions for smoking cessation in patients with coronary heart disease

Cited by 74 publications

References 204 publications

Can We Identify the Active Ingredients of Behaviour Change Interventions for Coronary Heart Disease Patients? A Systematic Review and Meta-Analysis

Can We Identify the Active Ingredients of Behaviour Change Interventions for Coronary Heart Disease Patients? A Systematic Review and Meta-Analysis

Trends in tobacco use among US adults with chronic health conditions: National Survey on Drug Use and Health 2005–2013

Feasibility and acceptability of a telephone‐ and face‐to‐face‐delivered counseling intervention for smoking cessation in Dutch patients with coronary heart disease

Contact Info

Product

Resources

About